Artículos de revistas
The Use Of Growth Hormone To Treat Endocrine-metabolic Disturbances In Acquired Immunodeficiency Syndrome (aids) Patients [o Papel Do Hormônio De Crescimento No Tratamento Dos Distúrbios Endócrino-metabólicos Do Paciente Com A Síndrome Da Imunodeficiência Adquirida (aids)]
Registro en:
Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 52, n. 5, p. 818 - 832, 2008.
42730
2-s2.0-51949110583
Autor
Spinola-Castro A.M.
Siviero-Miachon A.A.
Da Silva M.T.N.
Guerra Jr. G.
Institución
Resumen
Acquired Immunodeficiency Syndrome (Aids) was initially related to HIV-associated wasting syndrome, and its metabolic disturbances to altered body composition. After Highly Active Antiretroviral Therapy (HAART ) was started, malnutrition has declined and HIV-associated lipodystrophy syndrome has emerged as an important metabolic disorder. Aids is also characterized by hormonal disturbances, principally in growth hormone/insulin-like growth factor 1 (GH/IGF-1) axis. The use of recombinant human GH (hrGH) was formerly indicated to treat wasting syndrome, in order to increase lean body mass. Even though the use of hrGH in lipodystrophy syndrome has been considered, the decrease in insulin sensitivity is a limitation for its use, which has not been officially approved yet. Diversity in therapeutic regimen is another limitation to its use in Aids patients. The present study has reviewed the main HIV-related endocrine-metabolic disorders as well as the use of hrGH in such conditions. copyright© ABE&M todos os direitos reservados. 52 5 818 832 (2007) Unaids. Aids Epidemic Update, , http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf, December. Disponível em Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids (2007) Boletim Epidemiológico Aids-DST, (1). , Ministério da Saúde, Brasília: Ministério da Saúde, ano IV Leonard, E.G., McComsey, G.A., Metabolic complications of antiretroviral therapy in children (2003) Pediatr Infect Dis J, 22, pp. 77-84 Hirschfeld, S., Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection (1996) Horm Res, 46, pp. 215-221 Mulligan, K., Grunfeld, C., Hellerstein, M.K., Neese, R.A., Schambelan, M., Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection (1993) J Clin Endocrinol Metab, 77, pp. 956-962 Mynarcik, D.C., Frost, R.A., Lang, C.H., DeCristofaro, K., McNurlan, M.A., Garlick, P.J., Insulin-like growth factor system in patients with HIV infection: Effect of exogenous growth hormone administration (1999) J Acquir Immune Defic Syndr, 22, pp. 49-55 Hardin, D.S., Rice, J., Doyle, M.E., Pavia, A., Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection (2005) Clin Endocrinol (Oxf), 63, pp. 259-262 Gelato, M., McNurlan, M., Freedland, E., Role of recombinant human growth hormone in HIV-associated wasting and cachexia: Pathophysiology and rationale for treatment (2007) Clin Ther, 29, pp. 2269-2288 Viganò, A., Mora, S., Manzoni, P., Schneider, L., Beretta, S., Molinaro, M., Effects of recombinant growth hormone on visceral fat accumulation: Pilot study in human immunodeficiency virus-infected adolescents (2005) J Clin Endocrinol Metab, 90, pp. 4075-4080 Kotler DP, Muurahainen N, Grunfeld C, Wanke C, Thompson M, Saag M, et al. Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum. J Acquir Immune Defic Syndr. 2006;43:378-80Falutz, J., Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy (2007) Nat Clin Pract Endocrinol Metab, 3, pp. 651-661 Tesselaar, K., Miedema, F., Growth hormone resurrects adult human thymus during HIV-1 infection (2008) J Clin Invest, 3, pp. 844-847 Lo, J.C., Mulligan, K., Noor, M.A., Schwarz, J.M., Halvorsen, R.A., Grunfeld, C., The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation (2001) J Clin Endocrinol Metab, 86, pp. 3480-3487 Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe (2004) Aids, 18, pp. 1443-1451. , European Paediatric Lipodystrophy Group Ministério da Saúde. Brasil 2004. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids Brasília (PN DSTAids). Série Manuais no 60. [atualizaç ão não disponível acesso em 2008 Apr 28]. Disponível em: http://www.aids.gov.brZidovudine, didanosine, and zalcitabine in the treatment of HIV infection: Meta-analyses of the randomised evidence (1999) Lancet, 353, pp. 2014-2025. , HIV Trialists' Collaborative Group Chantry, C., Byrd, R., Englund, J., Baker, C.J., McKinney Jr, R.E., Pediatric Aids Clinical Trials Group Protocol 152 Study Team. Growth, survival and viral load in childhood HIV infection (2003) Pediatr Infect Dis J, 22, pp. 1033-1039 Wanke, C., Kotler, D., The HIV wasting collaborative consensus committee. Collaborative recommendations. The approach to diagnosis and treatment of HIV wasting (2004) J Acquir Immune Defic Syndr, 37 (SUPPL. 5), pp. S284-S288 Burgoyne, R.W., Tan, D.H., Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART ): A balancing act (2008) J Antimicrob Chemother, 61, pp. 469-473 Dreimane, D., Nielsen, K., Deveikis, A., Bryson, Y.J., Geffner, M.E., Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children (2001) Pediatr Infect Dis J, 20, pp. 315-316 Verweel, G., Van Rossum, A.M.C., Hartwig, N.G., Wolfs, T., Scherpbier, H.J., de Groot, R., Treatment with highly active antiretroviral therapy in human immunodeficiency virus type-1-infected children is associated with a sustained effect on growth (2002) Pediatrics, 109, pp. E25 Sterne, J.A., Hernán, M.A., Ledergerber, B., Tilling, K., Weber, R., Sendi, P., Swiss HIV cohort study. Long-term effectiveness of potent antiretroviral therapy in preventing Aids and death: A prospective cohort study (2005) Lancet, 366, pp. 378-384 Patel, K., Hernán, M.A., Williams, P.L., Seeger, J.D., McIntosh, K., Van Dyke, R.B., Pediatric Aids Clinical Trials Group 219/219C Study Team. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: A 10-year follow-up study (2008) Clin Infect Dis, 46, pp. 507-515 Scevola, D., DiMatteo, A., Giglio, O., Uberti, F., HIV infection-related cachexia and lipodystrophy (2006) Cachexia and wasting: A modern approach, pp. 407-428. , Mantovani G, editor, Milan: Springer; revised classification system for human immunodeficiency virus infection in children less than 13 years of age (1994) MMWR Morb Mortal Wkly Rep. 1994, 43, pp. 1-10. , Centers for Disease Control and Prevention Mangili, A., Murman, D.H., Zampini, A.M., Wanke, C.A., Nutrition and HIV infection: Review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort (2006) Clin Infect Dis, 42, pp. 836-842 Leonard, E.G., McComsey, G.A., Antiretroviral therapy in HIV-infected children: The metabolic cost of improved survival (2005) Infect Dis Clin North Am, 19, pp. 713-729 Polo, R., Gómez-Candela, C., Miralles, C., Locutura, J., Alvarez, J., Barreiro, F., SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA. Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient (2007) Nutr Hosp, 22, pp. 229-243 Chantry, C.J., Frederick, M.M., Meyer 3rd, W.A., Handelsman, E., Rich, K., Paul, M.E., Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children (2007) Pediatr Infect Dis J, 26, pp. 53-60 Valente, A.M.M., Reis, A.F., Machado, D.M., Succi, R.C.M., Chacra, A.R., Alterações metabólicas da síndrome lipodistrófica do HIV. (2005) Arq Bras Endocrinol Metab, 49, pp. 871-881 Saint-Marc, T., Partisani, M., Poizot-Martin, I., Bruno, F., Rouviere, O., Lang, J.M., A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy (1999) Aids, 13, pp. 1659-1667 Lundgren, J.D., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., EACS Executive Committee. European Aids Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV (2008) HIV Medicine, 9, pp. 72-81 Laue, L., Pizzo, P.A., Butler, K., Cutler Jr., G.B., Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome (1990) J Pediatr, 117, pp. 541-545 Matarazzo, P., Palomba, E., Lala, R., Ciuti, E., Altare, F., de Sanctis, L., Growth impairment, IGF I hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection (1994) Acta Paediatr, 83, pp. 1029-1034 Panamonta, O., Kosalaraksa, P., Thinkhamrop, B., Kirdpon, W., Ingchanin, C., Lumbiganon, P., Endocrine function in Thai children infected with human immunodeficiency virus (2004) J Pediatr Endocrinol Metab, 17, pp. 33-40 Rondanelli, M., Caselli, D., Aricò, M., Maccabruni, A., Magnani, B., Bacchella, L., Insulin-like growth factor I (IG F-I) and IG F-binding protein 3 response to growth hormone is impaired in HIV-infected children (2002) Aids Res Hum Retroviruses, 18, pp. 331-339 Fliers, E., Unmehopa, U.A., Manniesing, S., Vuijst, C.L., Wiersinga, W.M., Swaab, D.F., Decreased neuropeptide Y (NPY) expression in the infundibular nucleus of patients with nonthyroidal illness (2001) Peptides, 22, pp. 459-465 Eledrisi, M.S., Verghese, A.C., Adrenal insufficiency in HIV infection: A review and recommendations (2001) Am J Med Sci, 321, pp. 137-144 Tovo, P.A., de Martino, M., Gabiano, C., Cappello, N., D'Elia, R., Loy, A., Prognostic factors and survival in children with perinatal HIV infection (1992) Lancet, 339, pp. 1249-1253 Nachman, S.A., Lindsey, J.C., Pelton, S., Mofenson, L., McIntosh, K., Wiznia, A., Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy (2002) Arch Pediatr Adolesc Med, 156, pp. 497-503 Congote, L.F., Monitoring insulin-like growth factors in HIV infection and aids (2005) Clin Chim Acta, 361, pp. 30-53 Meininger, G., Grinspoon, S., Regulation of the growth hormone/ insulin-like growth factor-I axis in HIV disease (2001) Endocrinologist, 11, pp. 188-195 Frost, R.A., Fuhrer, J., Steigbigel, R., Mariuz, P., Lang, C.H., Gelato, M.C., Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system (1996) Clin Endocrinol (Oxf), 44, pp. 501-514 Heijligenberg, R., Sauerwein, H.P., Brabant, G., Endert, E., Hommes, M.J., Romijn, J.A., Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome (1996) J Clin Endocrinol Metab, 81, pp. 4028-4032 Rondanelli, M., Solerte, S.B., Fioravanti, M., Scevola, D., Locatelli, M., Minoli, L., Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone and prolactin during HIV infection (1997) Aids, 13, pp. 1243-1249 Stanley TL, Grinspoon SK. GH/GHRH axis in HIV lipodystrophy. Pituitary. 2008 Feb 13 [Epub ahead of print]Viganò, A., Mora, S., Brambilla, P., Schneider, L., Merlo, M., Monti, L.D., Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV- infected adolescents (2003) Aids, 17, pp. 1435-1441 Van Rossum, A.M.C., Gaaker, M.I., Verweel, G., Hartwig, N.G., Wolfs, T.F., Geelen, S.P., Endocrinology and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors (2003) Pediatric Infect Dis J, 22, pp. 70-76 Schambelan, M., Mulligan, K., Grunfeld, C., Daar, E.S., LaMarca, A., Kotler, D.P., Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group (1996) Ann Intern Med, 125, pp. 873-882 Krentz, A.J., Koster, F.T., Crist, D.M., Finn, K., Johnson, L.Z., Boyle, P.J., Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in Aids and Aids-related complex (1993) J Acquir Immune Defic Syndr, 6, pp. 245-251 McNurlan, M.A., Garlick, P.J., Steigbigel, R.T., DeCristofaro, K.A., Frost, R.A., Lang, C.H., Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease (1997) J Clin Invest, 100, pp. 2125-2132 Waters, D., Danska, J., Hardy, K., Koster, F., Qualls, C., Nickell, D., Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in Aids-associated wasting: A randomized, double-blind, placebocontrolled trial (1996) Ann Intern Med, 125, pp. 865-872 Esposito, J.G., Thomas, S.G., Kingdon, L., Ezzat, S., Growth hormone treatment improves peripheral muscle oxygen extraction-utilization during exercise in patients with human immunodeficiency virus-associated wasting: A randomized controlled trial (2004) J Clin Endocrinol Metab, 89, pp. 5124-5131 Moyle, G.J., Daar, E.S., Gertner, J.M., Kotler, D.P., Melchior, J.C., O'Brien, F., Serono 9037 Study Team. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy (2004) J Acquir Immune Defic Syndr, 35, pp. 367-375 Storer, T.W., Woodhouse, L.J., Sattler, F., Singh, A.B., Schroeder, E.T., Beck, K., A randomized, placebocontrolled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment (2005) J Clin Endocrinol Metab, 90, pp. 4474-4482 Wanke, C., Gerrior, J., Kantaros, J., Coakley, E., Albrecht, M., Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV (1999) Aids, 13, pp. 2099-2103 Zeitler, P.S., Travers, S., Kappy, M.S., Advances in the recognition and treatment of endocrine complications in children with chronic illness (1999) Adv Pediatr, 46, pp. 101-149 Napolitano, L.A., Schmidt, D., Gotway, M.B., Ameli, N., Filbert, E.L., Ng, M.M., Growth hormone enhances thymic function in HIV-infected adults (2008) J Clin Invest, 118, pp. 1085-1098